baber/WOPTO huggingface dataset:
Patent WO-2019161441-A1 (WO)
Title: Oro-nasal patient interface for treating sleep disordered breathing
Inventor: DODDS CHRISTOPHER
IPC: A61M16/06
Filed: 2019-02-18
Abstract: A patient interface (200, 300) comprising: a seal-forming structure (210, 220, 310, 320) including a face-engaging surface that is personalised to the patient's facial contour and to form a seal with the patient's face at least on or below the bridge of the patient's nose and between the patient's lower lip and on or above the patient's chin, preferably proximal to the patient's mentolabial crease, the face- engaging surface including at least one nare port (211, 311) shaped and sized to align with the patient's nares; an anterior surface (205, 305) including a connection port; wherein the seal-forming structure (210, 220, 310, 320) is non- deformable in response to headgear tension or pressurised air received within the seal-forming structure (210, 220, 310, 320).
Patent AU-2019201941-A1 (AU)
Title: Computing long-term schedules for data transfers over a wide area network
Inventor: KANDULA SRIKANTH
IPC: H04L45/121
Filed: 2019-03-20
Abstract: A method comprising: receiving a request to transfer data from a first computing device in a network to a 5 second computing device in the network, the request identifying: the second computing device; a volume of data to be transferred from the first computing device to the second computing device in accordance with the request; and a deadline, the transfer of the data from the first computing device to the 10 second computing device to be completed prior to the deadline; responsive to receiving the request and based upon the request, executing an optimization process to compute a long-term schedule that covers a plurality of time units, the long-term schedule generated to facilitate completion of the transfer of the data from the first computing device to the second computing device prior to the deadline, the long 15 term schedule identifies, for a time unit in the plurality of time units, at least one path in the network over which the data is to be transferred from the first computing device to the second computing device; based upon the long-term schedule, computing a short-term schedule, the short term schedule computed to facilitate completion of the transfer of the volume of the data 20 from the first computing device to the second computing device prior to the deadline, the short-term schedule comprising a routing table for a network infrastructure device in the network, the routing table identifies at least one device to which data received by the network infrastructure device is to be transferred; and transmitting the routing table to the network infrastructure device. C)o =0 oS uJ 0 0 0 U- M Zn r4D ZeZ Uo 0 L ¾- > DOL ~LLJ 00t z cc 0 ri00 LUuju to LLUJr 1/9 9-.
Patent AU-2019202146-A1 (AU)
Title: System and method for outlier identification to remove poor alignments in speech synthesis
Inventor: RAGHAVENDRA E VEERA
IPC: G10L13/02
Filed: 2019-03-28
Abstract: The present invention relates to a method and system for outlier identification to remove poor alignments in speech synthesis. The identification of poor alignment is based on fundamental frequency methods and group delay-based outlier detection methods, wherein instances of phonemes in a sentence are identified as outliers based on the above fundamental frequency and group delay methods and if the sentence has more than a given number of outliers, discarding the sentence from speech model training.
Patent AU-2019204449-A1 (AU)
Title: Process for growing nanowires or nanopyramids on graphitic substrates
Inventor: KIM DONG-CHUL
IPC: H01L21/20
Filed: 2019-06-25
Abstract: A process for growing nanowires or nanopyramids comprising: (I) providing a graphitic substrate and treating said graphitic substrate with nitrogen plasma at an elevated temperature to incorporate nitrogen into said graphitic substrate or/and to form atomic steps/ledges; (II) growing a plurality of semiconducting group III-V nanowires or nanopyramids on the treated graphitic surface, preferably via MOVPE or MBE. Figure la GaN or AIGaN or AIN orin GaN nanowire AIGaN or AIN or AGainN or InGaN buffer layer Bufferliayer Graphitic substrate Gaphitic substrate SupportSuppor t Figure lb GaNorAIGaNorAIN AIGaN or AlNor AIGalnN or inGaN nanowire or inGaN nucleation island Nucleation island Graphitic substrate Gr aphi tic substrate Support Suppor t
Patent AU-2019211412-A1 (AU)
Title: System, software and methods for remote gardening
Inventor: BORLIK CRAIG
IPC: H04L29/08
Filed: 2019-01-24
Abstract: A method of allowing a remote client to control a garden plot is described. The garden plot may be provided with electronically controlled watering devices for remote watering of the garden plot and a 360 degree zoom camera for remote viewing of the gardening plot. The method may include an application server for receiving client instructions, one or more modules for optimizing a planting layout, handling watering instructions, handling camera instructions, handling harvesting instructions, and conducting a virtual and/or local farmer's market to maximize use of the harvest.
Patent AU-2019216625-A1 (AU)
Title: Genetically modified non-human animals and methods of use thereof
Inventor: FLAVELL RICHARD A
IPC: A01K67/027
Filed: 2019-08-13
Abstract: 1:\Interwovn\NRPortbl\DCC\FMT\19179005_I.DOCX-13/08/2019 The invention relates generally to genetically modified non-human animals expressing human polypeptides and their methods of use.
Patent AU-2019223049-A1 (AU)
Title: 3beta-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disorders
Inventor: PIAZZA PIER VINCENZO
IPC: A61P25/30
Filed: 2019-02-20
Abstract: The present invention generally relates to a specific pregnenolone derivative for its use for the treatment of a Cannabinoids-Related Disorder. More particularly, the invention relates to a compound of Formula (I), for its use in the treatment of a Cannabinoids-Related Disorder. Indeed, the compound of the invention is
Patent AU-2019226152-A1 (AU)
Title: System and method for manufacturing parametric parts
Inventor: SYKES OLIVER WILLIAM
IPC: G06K9/46
Filed: 2019-09-03
Abstract: SYSTEM AND METHOD FOR MANUFACTURING PARAMETRIC A method and apparatus for manufacturing apart (102). The part (102) is designed using a CAD system (108) to generate a CAD part model of the part (102). Features of the part are identified from the CAD part model of the part (102). A parametric specification of the part (102) is generated using the features of the part (102). The parametric specification of the part (102) is saved as a parametric part model. The parametric part model is used to fabricate the part (102). u-c, 0n I- o= cn z ci, U- L zC4 0 c I--
Patent AU-2019231316-A1 (AU)
Title: Methods for detecting microorganisms using microorganism detection protein and other applications of cell binding components
Inventor: ERICKSON STEPHEN
IPC: C12N1/02
Filed: 2019-03-11
Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms using a cell binding component (CBC). The specificity of CBSs for binding microorganisms allows targeted and highly specific detection of a microorganism of interest.
Patent AU-2019232139-A1 (AU)
Title: Compounds for treating Alzheimer's disease
Inventor: GARNIER PATRICE
IPC: A61K31/519
Filed: 2019-03-07
Abstract: The present invention relates to a compound of the following formula (I): (I) or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of Alzheimer's disease in an individual.
Patent AU-2019253831-A1 (AU)
Title: Compositions and methods for treating neurodegenerative diseases
Inventor: BROWNSTEIN MICHAEL J
IPC: A61P25/28
Filed: 2019-10-23
Abstract: 594-12599 Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treating neuropsychiatric aspects of neurodegenerative diseases such as Huntington's Disease, Parkinson's Disease, and Alzheimer's Disease. V-
Patent AU-2019261205-A1 (AU)
Title: Washing machine and control method thereof
Inventor: IM MYUNGHUN
IPC: D06F33/30
Filed: 2019-04-24
Abstract: A method of controlling a washing machine includes: sensing a laundry amount accommodated in a drum; performing water supply into the drum according to the sensed laundry amount; rotating a pump motor at a certain initial rotation speed and transferring washing water discharged from the drum to at least one nozzle for spraying water into the drum; sensing a water level in the drum; performing a re-supply of water at least once until the sensed water level reaches a set water level; and increasing the rotation speed of the pump motor whenever the re-supply of water is performed, so that as the rotation speed of the pump motor is increased, the reaching range of the water stream sprayed through the nozzle gradually expands from the lower side of the circumferential surface of the drum to the rear surface of the drum.
Patent AU-2019263679-A1 (AU)
Title: Joining system for floor panels
Inventor: MARKOVSKI BOBBY
IPC: E04F15/02
Filed: 2019-05-03
Abstract: The invention relates to Joining system for floor panels (1). The floor panels (1) are provided with coupling parts (20) on at least two opposite sides (30, 40) for joining floor panels (1) together. The coupling parts (20) include a groove (50) and a tongue (60), where the groove (50) is shaped for insertion of a tongue (60) on an adjoining floor panel (1). The tongue (60) is shaped for locking engagement by means of integrated locking means (70) with the groove (50) in a direction perpendicular to said sides (30, 40) and parallel to a horizontal floor plane (FP) defined by the joined panels (1). The invention is especially characterized in that: - the locking means (70) comprises dual consecutive locking recesses (80, 90) arranged in a lower portion (95) of the groove (50), a first locking recess (80) of which being located in an internally extending portion (100) within the groove (50) and a second locking recess (90) of which being located in a lip portion (110) protruding from an entrance opening (120) of the groove (50), the locking means (70) further comprises dual consecutive locking lugs (130, 140) arranged in a lower portion (150) of the tongue (60) for horizontally interlocking engagement with said dual consecutive locking recesses (80, 90) in the groove (50), a first locking lug (130) of which extending downwardly from a lower tip portion (160) of the tongue (60) and a second locking lug (140) of which extending downwardly from a root portion (170) of the tongue (60), wherein the first locking recess (80) and the first locking lug (130) are provided with matching curved horizontal locking surfaces (180, 190) and wherein the second locking recess (90) and the second locking lug (140) are provided with matching inclined horizontal locking surfaces (200, 210).
Patent AU-2019274870-A1 (AU)
Title: Method of treating pain or interstitial cystitis using indole compound
Inventor: UEDA YOSHIFUMI
IPC: A61K31/5377
Filed: 2019-05-24
Abstract: Provided is a therapeutic or prophylactic agent for pain or interstitial cystitis comprising N-[2-(6,6-dimethyl-4,5,6,7-tetrahydro-lH-indazol-3-yl)-lH-indol-6-yl]-N- methyl-(2S)-2-(morpholin-4-yl)propanamide or a pharmaceutically acceptable salt thereof.
Patent AU-2019288296-A1 (AU)
Title: Sustained-release drug delivery systems comprising an intraocular pressure lowering agent, a CNP compound, an NPR-B compound, a Tie-2 agonist, or neurotrophic agent for use for treating glaucoma or ocular hypertension
Inventor: SCHIFFMAN RHETT M
IPC: A61K9/08
Filed: 2019-06-18
Abstract: This disclosure relates to a drug delivery system comprising an intraocular pressure lowering agent, a neurotrophic agent, such as a CNTF compound, a C-type Natriuretic Peptide (CNP) compound, a Tie-2 agonist, a Natriuretic Peptide Receptor-B (NPR-B) compound, or an apoptosis signaling fragment inhibitor (FAS) or FAS-ligand (FASL) inhibitor, including any combination of these compounds and a sustained delivery component. Methods of treating a glaucoma or related conditions, medicaments, kits, uses and methods of manufacturing are also described.
Patent AU-2019295731-A1 (AU)
Title: Eye treatment apparatus and method with independent pressure sources
Inventor: BERDAHL JOHN
IPC: A61H35/02
Filed: 2019-06-27
Abstract: An apparatus can include a left cover, sized and shaped to fit over a left eye of a patient to define a left cavity between the left cover and an anterior surface of the left eye and a right cover, sized and shaped to fit over a right eye of the patient to define a right cavity between the right cover and an anterior surface of the right eye. The apparatus can include a left pressure source to apply a left working fluid to the left cavity, the left pressure source capable of generating a left cavity pressure including a left negative gauge pressure and a right pressure source to apply a right working fluid to the right cavity, the right pressure source capable of generating a right cavity pressure including a right negative gauge pressure, where the right pressure source can be separate from the left pressure source. The left pressure source can be configured to generate a left cavity pressure independently of the right pressure source and the right pressure source can be configured to generate a right cavity pressure independently of the left pressure source.
Patent AU-2019304308-A1 (AU)
Title: Bioactive extract
Inventor: LOUSSIER THOMAS
IPC: A61K36/074
Filed: 2019-07-18
Abstract: The present invention provides a composition for human or animal consumption, preferably with antiviral, antibacterial, antifungal, antiprotozoal, immune boosting and/or toxin resistance activities. The composition includes a fungal extract component and optionally a fruit extract component. The invention also provides methods for producing the composition and methods of using the composition.
Patent AU-2019336559-A1 (AU)
Title: Diagnosis of cancer
Inventor: ALSWORTH MAX
IPC: G01N33/574
Filed: 2019-09-04
Abstract: A method for the early detection and monitoring of the progression of cancer by detecting breath biomarkers is provided. The method comprises assessing the activity of an aldo-keto reductase by measuring the concentration of an exogenous substrate for said enzyme and/or measuring the concentration of a metabolite of said substrate in exhaled breath of a subject. Preferably, the cancer is lung cancer.
Patent AU-2019341653-A1 (AU)
Title: Selective salmonella or E. coli cultivation method, compositions and uses
Inventor: ILLINGWORTH DAVID SIMON
IPC: A01N43/60
Filed: 2019-09-18
Abstract: The present disclosure provides rapid, convenient and sensitive means to detect low abundance target Gram negative bacteria such as Salmonella contamination from a range of samples, including food samples and environmental samples, through a single-step culture method and downstream sensitive detection.
Patent AU-2019377115-A1 (AU)
Title: Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
Inventor: SIMONS EMMANUEL J
IPC: C07K14/47
Filed: 2019-11-07
Abstract: Provided herein are compositions that include at least two different nucleic acid vectors that, when introduced into a primate cell, the at least two different vectors undergo concatamerization or homologous recombination with each other, thereby forming a recombined nucleic acid that encodes a full-length target protein (e.g., a supporting cell target protein or a hair cell target protein). Also provided are compositions that include a single AAV vector that, when introduced into a primate cell, a nucleic acid encoding a full-length target protein (e.g., a supporting cell target protein or a hair cell target protein) is generated at the locus of the supporting cell target gene, and the primate expresses the target protein (e.g., a supporting cell target protein or a hair cell target protein).
Patent AU-2019377275-A1 (AU)
Title: Method for reducing the risk of a cardiovascular event with conjugated antisense compounds targeting apo(a)
Inventor: LESOGOR ANASTASIA
IPC: A61K31/7125
Filed: 2019-11-08
Abstract: The present disclosure is directed to methods of reducing the risk of a cardiovascular event with conjugated antisense compounds targeting apo(a). Specifically, a method of reducing the risk of a cardiovascular event in a patient who has established cardiovascular disease with conjugated antisense compound ISIS 681257 or a salt thereof.
Patent AU-2019380007-A1 (AU)
Title: Receptacle socket assembly for lighting equipment
Inventor: THIJS MARCEL
IPC: H01R13/502
Filed: 2019-11-12
Abstract: A receptacle socket assembly for lighting equipment comprising: a receptacle having a front side for receiving contacts of a control module, said receptacle housing a plurality of receptacle contacts, each receptacle contact being provided, at a front end, with a front contact portion for being electrically connected with a contact of a control module, and, at a rear end, with a rear contact portion; a wire connector having a front side and a rear side, said wire connector housing a plurality of connector contacts, each connector contact being provided, at a rear end, with a wire receiving contact for receiving and fixing a wire end and, at a front end, with a front contact portion; wherein the rear side of the receptacle and the front side of the wire connector are configured such that the wire connector is removably pluggable in the rear side of the receptacle.
Patent AU-2019431390-A1 (AU)
Title: Folding ladder
Inventor: YILDIZ OGUZHAN
IPC: E06C1/383
Filed: 2019-12-05
Abstract: Folding ladder (1), in particular for accessing the cavity of a lift shaft comprising: a first side rail (2) and a second side rail (3) that are parallel; a plurality of rungs (10); a stop (15) located on the first side rail (2); a locking member (16) located on the second side rail (3); a locking arm (34) having a first end portion (34a) pivotally attached to the first side rail (2) and a second end portion (34b) that is movable between an unlocking position in which it is magnetically coupled to the stop (15) so that the locking arm (34) abuts the first side rail (2), and a locking position in which it is magnetically coupled to the locking member (16) so that the locking arm (34) is diagonally arranged with respect to both the side rails (2, 3).
Patent WO-2020163907-A1 (WO)
Title: Mécanisme à charnière d'une fermeture poly-axiale
Inventor: TIPPER GAIN
IPC: E05D7/14
Filed: 2020-02-11
Abstract: La présente invention concerne une charnière de fermeture poly-axiale qui comprend un ensemble charnière primaire et un ensemble charnière secondaire ayant un second axe de pivot qui est sensiblement parallèle à l'axe de charnière primaire et espacé de celui-ci. Un ensemble de verrouillage de charnière est conçu pour fixer le mouvement des charnières primaire et secondaire l'un par rapport à l'autre autour de l'axe de pivot secondaire lorsqu'il est déplacé de la position fermée et permet un mouvement limité de la charnière secondaire par rapport à la charnière primaire lorsqu'il est dans la position fermée.
Patent WO-2020168389-A1 (WO)
Inventor: LIU DONGXI
IPC: H04L9/00
Filed: 2020-02-21
Abstract: A method (100) for block generation in a distributed ledger is presented. Each client device of a plurality of client devices (302) to (308) defines an associated battery (200). Each battery (200) comprises a proof-of-work (PoW) (202) and a unique identifier (204) of the associated client device. Each of the plurality of client devices (302) to (308) broadcasts the associated battery (200) to a plurality of nodes that maintain the distributed ledger. The plurality of nodes record the battery in the distributed ledger and select, via a battery selection algorithm, a first battery associated with a first client device to generate a new block in the distributed ledger. The first client device generates the new block using the first battery.
Patent AU-2020201779-A1 (AU)
Title: Method for using gene expression to determine prognosis of prostate cancer
Inventor: SHAK STEVEN
IPC: C12Q1/68
Filed: 2020-03-11
Abstract: Molecular assays that involve measurement of expression levels of prognostic biomarkers, or co expressed biomarkers, from a biological sample obtained from a prostate cancer patient, and analysis of the measured expression levels to provide information concerning the likely prognosis for said patient, and likelihood that said patient will have a recurrence of prostate cancer, or to classify the tumor by likelihood of clinical outcome or TMPRSS2 fusion status, are provided herein.
Patent AU-2020202624-A1 (AU)
Title: Valve assemblies for surgical access assemblies
Inventor: DININO MATTHEW
IPC: A61B1/32
Filed: 2020-04-17
Abstract: VALVE ASSEMBLIES FOR SURGICAL ACCESS ASSEMBLIES 
ABSTRACT 
A surgical access assembly (100) comprising: an instrument valve housing (110) 
including upper and lower housing sections defining a cavity, the upper housing section having 
an outward facing surface and the lower housing section having an inward facing surface; and a 
valve assembly (140) disposed within the cavity of the instrument valve housing (110), the valve 
assembly (140) including: a guard assembly (160); a seal assembly (170) disposed adjacent to 
the guard assembly (160), the seal assembly (170) having a nonsolid inner circumference; and a 
gimbal mount assembly (150) supporting the guard assembly (160) and the seal assembly (170), 
the gimbal mount assembly (150) including an outer semispherical surface in operable 
engagement with the inward facing surface of the lower housing section and an inner surface in 
operable engagement with the outward facing surface of the upper housing section, wherein the 
gimbal mount assembly (150) is configured to permit angulation of the valve assembly (140) 
relative to the instrument valve housing (110).
Patent AU-2020203035-A1 (AU)
Title: CDK Inhibitors
Inventor: TAVARES FRANCIS X
IPC: C07D487/14
Filed: 2020-05-07
Abstract: Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
Patent AU-2020212092-A1 (AU)
Title: Combination of overhead air-conditioning unit
Inventor: CHEN JIANMIN
IPC: F24F13/02
Filed: 2020-01-15
Abstract: Disclosed is a combination of an overhead air-conditioning unit, the combination comprising an overhead unit, a roof (7), connection air pipes and an air distribution box, wherein the overhead unit is provided on an outer wall face of the roof (7); a chassis (1) of the overhead unit has an air outlet (2); the air distribution box is provided on an inner wall face of the roof (7); the air distribution box has an air inlet feeding channel (9); the plurality of connection air pipes communicate the air outlet (2) of the overhead unit and the air inlet feeding channel (9) of the air distribution box via an opening (8) of the roof (7); and an adjustment part for adjusting a thickness gap (10) of the roof (7) is provided around the air outlet (2) of the chassis. The combination simplifies the complexity of assembly, so that an installation process is simpler, thereby also reducing costs.